tenk.fyi

Inhibikase Therapeutics, Inc.

IKTNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$48.3M

75.4% YoY

EPS

$-0.49

57.8% YoY

Cash

$178.8M

83.4% YoY

FY 2025 · As of 2025-12-31